Abstracts
Purpose: Low Bone mineral density (BMD) are common in patients with infl ammatory bowel diseases and is a leading causes of morbidity in such patients. Data about bone disease in male UC patients is scarce. Or aim was to assess the prevalence of low BMD among male UC patients on a nationwide level. Methods: Nationwide data was obtained from the Veterans Aff airs (VA) healthcare system. Male veterans seen by the VA between 2001-2011 were identifi ed using ICD-9 and were included in our analysis. Automated data extraction captured information about the veterans demographics, presence of bone disease and most important risk factors [corticosteroid (CS) use, hyperparathyroidism, hypogonadism, malnutrition, vitamin D defi ciency and smoking]. Th e rate of bone disease by cumulative CS decile was calculated. Multivariate logistic regression analysis was used to identify the independent eff ect of each factor on bone disease. Results: We included 34,665 male UC patients (mean age 66, Caucasians 75%). Prevalence of osteoporosis among the included population was 6.5%, while for osteopenia it was 4.3%. Th ose who used CS (30% of the included population with mean duration of 9 months) had higher prevalence of bone diseases (10.2% and 7%) compared to those who did not use CS (4.8% and 3.2%) for osteoporosis and osteopenia respectively, p<0.001. By using multivariate analysis, we found that cumulative oral CS deciles was the most signifi cant predictor of bone disease and showed a signifi cant trend (dose-response) pattern even in those with lowest decile of cumulative CS exposure, Table 1 . Conclusion: In this large nationwide male UC cohort, 41% of those in the highest CS use decile had osteoporosis or osteopenia. CS use is the most important independent risk factor for low bone density among UC male patients. Eff orts should be taken to reduce CS utilization among these patients by using other immunosuppressant agents. Purpose: We recently completed a retrospective case-control study showing a signifi cant association between obesity and endoscopic disease activity in Crohn's (CD). Th is association was independent of age, gender, ethnicity, and disease duration and observation period. Because lower socioeconomic status (SES) is associated with obesity, we tested whether higher SES is independently associated with lower endoscopic disease activity in CD. Methods: Health insurance status was used as a measure of SES as we were not able to fi nd complete data on income, highest education attained or profession. Balanced sampling was maintained with no signifi cant demographic or clinical diff erences detected between cases and controls. Despite a fi xed sample size of 104, this was suffi cient to power (>80%) to detect a clinically meaningful 15% diff erence in eff ect size of insurance status between the two groups with alpha of 5%. Eligible patients were >19 years old, and had BMI and endoscopic data at beginning and end of the observation (2005) (2006) (2007) (2008) (2009) (2010) . We compared patients with active ulcerating endoscopic disease (cases) to those in endoscopic remission (controls) at the end of observation based on insurance status and type of insurance using chi-square testing. Adjusted logistic regression models were examined to evaluate eff ect of insurance status and type of insurance on endoscopic disease. Th e level of signifi cance was assessed at p < 0.05 that was not adjusted for multiplicity of testing as insurance status constituted additional data. Results: 36 cases and 68 controls were identifi ed. 78% vs. 84% of the cases and controls held health insurance respectively (P=0.448). 58% vs. 62% of cases vs. controls had private health insurance (P=0.733). Logistic regression analysis adjusting for age, gender, ethnicity, disease duration, observation period and obesity failed to demonstrate any signifi cant impact of health insurance on 
